These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Correction: HIV Reactivation from Latency after Treatment Interruption Occurs on Average Every 5-8 Days-Implications for HIV Remission. Pinkevych M; Cromer D; Tolstrup M; Grimm AJ; Cooper DA; Lewin SR; Søgaard OS; Rasmussen TA; Kent SJ; Kelleher AD; Davenport MP PLoS Pathog; 2016 Aug; 12(8):e1005745. PubMed ID: 27561082 [TBL] [Abstract][Full Text] [Related]
3. Correction: Fatal Prion Disease in a Mouse Model of Genetic E200K Creutzfeldt-Jakob Disease. Friedman-Levi Y; Meiner Z; Canello T; Frid K; Kovacs GG; Budka H; Avrahami D; Gabizon R PLoS Pathog; 2017 May; 13(5):e1006294. PubMed ID: 28467504 [TBL] [Abstract][Full Text] [Related]
4. Correction: Increased Abundance of M Cells in the Gut Epithelium Dramatically Enhances Oral Prion Disease Susceptibility. PLOS Pathogens Staff PLoS Pathog; 2017 Feb; 13(2):e1006222. PubMed ID: 28212438 [TBL] [Abstract][Full Text] [Related]
11. Correction: Wolbachia Blocks Viral Genome Replication Early in Infection without a Transcriptional Response by the Endosymbiont or Host Small RNA Pathways. PLOS Pathogens Staff PLoS Pathog; 2016 May; 12(5):e1005639. PubMed ID: 27159401 [TBL] [Abstract][Full Text] [Related]
12. Correction: 24 Hours in the Life of HIV-1 in a T Cell Line. Mohammadi P; Desfarges S; Bartha I; Joos B; Zangger N; Muñoz M; Günthard HF; Beerenwinkel N; Telenti A; Ciuffi A PLoS Pathog; 2015 Jun; 11(6):e1005006. PubMed ID: 26076473 [TBL] [Abstract][Full Text] [Related]
13. Correction: Distinct Roles of Type I and Type III Interferons in Intestinal Immunity to Homologous and Heterologous Rotavirus Infections. Lin JD; Feng N; Sen A; Balan M; Tseng HC; McElrath C; Smirnov SV; Peng J; Yasukawa LL; Durbin RK; Durbin JE; Greenberg HB; Kotenko SV PLoS Pathog; 2016 Jun; 12(6):e1005726. PubMed ID: 27304875 [TBL] [Abstract][Full Text] [Related]
16. Correction: BILBO1 is a scaffold protein of the flagellar pocket collar in the pathogen Trypanosoma brucei. Florimond C; Sahin A; Vidilaseris K; Dong G; Landrein N; Dacheux D; Albisetti A; Byard EH; Bonhivers M; Robinson DR PLoS Pathog; 2015 Apr; 11(4):e1004844. PubMed ID: 25874582 [TBL] [Abstract][Full Text] [Related]
17. Distribution of intraneuronal immunoreactivity for the prion protein in human prion diseases. Kovacs GG; Voigtländer T; Hainfellner JA; Budka H Acta Neuropathol; 2002 Sep; 104(3):320-6. PubMed ID: 12172919 [TBL] [Abstract][Full Text] [Related]
18. Polyclonal anti-idiotypic antibodies which mimic an epitope of the human prion protein. Hanoux V; Wijkhuisen A; Alexandrenne C; Créminon C; Boquet D; Couraud JY Mol Immunol; 2009 Mar; 46(6):1076-83. PubMed ID: 19012967 [TBL] [Abstract][Full Text] [Related]
19. Correction: Role of pentraxin 3 in shaping arthritogenic alphaviral disease: from enhanced viral replication to immunomodulation. PLOS Pathogens Staff PLoS Pathog; 2015 Apr; 11(4):e1004797. PubMed ID: 25875364 [TBL] [Abstract][Full Text] [Related]
20. Monoclonal antibodies inhibit prion replication and delay the development of prion disease. White AR; Enever P; Tayebi M; Mushens R; Linehan J; Brandner S; Anstee D; Collinge J; Hawke S Nature; 2003 Mar; 422(6927):80-3. PubMed ID: 12621436 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]